Home / Healthcare / Pharmaceutical / U.S. CAR-T Cell Therapy Market

U.S. CAR-T Cell Therapy Market Size, Share & Industry Analysis, By Drug (Yescarta, Tecartus, Carvykti, Abecma, Breyanzi, Kymriah, and Others), By Indication (Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma (NHL), and Multiple Myeloma), By End-user (Hospitals and Oncology Treatment Centers), and Country Forecast, 2024-2032

Report Format: PDF | Published Date: Sep, 2024 | Report ID: FBI109015 | Status : Published
  • USA
  • 2023
  • 70
  • PRICE
  • $ 2850
    $ 3850
    $ 4850
    Buy Now

Healthcare Clients